BIIB vs DRI · P/E 21, rev $9.89B vs P/E 22, rev $13.21B
Biogen Inc (BIIB) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DRI revenue for 2026-05-31 was $13.21B. Net income was $1.21B. Revenue was up 9.4% from 2025-05-25 to 2026-05-31. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the BIIB and DRI stock pages for the full models.
Not investment advice.